Status:
COMPLETED
Lactobacillus Rhamnosus GG: Interaction With Human Microbiota and Immunity
Lead Sponsor:
Turku University Hospital
Collaborating Sponsors:
Academy of Finland
Mead Johnson Nutrition
Conditions:
Gut Microbiota
Skin Microbiota
Eligibility:
All Genders
4-18 years
Phase:
PHASE4
Brief Summary
Hypothesis: Probiotics have been used as novel adjunct therapeutic approach in atopic dermatitis. In addition to balancing the gut microecology and promoting host immune defences, specific probiotics ...
Eligibility Criteria
Inclusion
- clinical diagnosis of atopic dermatitis
- age 4 we - 18 mo
Exclusion
- skin infection or severe infection at the time of enrollment
Key Trial Info
Start Date :
March 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2008
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT01148667
Start Date
March 1 2007
End Date
July 1 2008
Last Update
June 22 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Turku University Central Hospital
Turku, Finland, 20520